Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common stock and additional paid-in capital	Retained earnings	Accumulated other comprehensive income (loss)
Beginning balance (in shares) at Dec. 31, 2024		11,155,528
Balance at beginning of period at Dec. 31, 2024	$ 252,493	$ 71,944	$ 222,823	$ (42,274)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	7,077		7,077
Net unrealized (loss) gain on securities available for sale, net of taxes	3,969			3,969
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax	2			2
Net unrealized loss on hedging derivative instruments, net of tax	(75)			(75)
Comprehensive income (loss)	10,973		7,077	3,896
Cash dividends declared	(4,031)		(4,031)
Equity compensation expense	298	$ 298
Payment to repurchase common stock (in shares)		(10,784)
Payment to repurchase common stock	(277)		(277)
Issuance of restricted stock (in shares)		43,297
Proceeds from sale of common stock (in shares)		8,840
Proceeds from sale of common stock	$ 225	$ 225
Ending balance (in shares) at Mar. 31, 2025	11,196,881	11,196,881
Balance at end of period at Mar. 31, 2025	$ 259,681	$ 72,467	225,592	(38,378)
Beginning balance (in shares) at Dec. 31, 2025	11,222,363	11,222,363
Balance at beginning of period at Dec. 31, 2025	$ 283,143	$ 73,826	240,456	(31,139)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	8,993		8,993
Net unrealized (loss) gain on securities available for sale, net of taxes	(1,449)			(1,449)
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax	3			3
Net unrealized loss on hedging derivative instruments, net of tax	0
Comprehensive income (loss)	7,547		8,993	(1,446)
Cash dividends declared	(4,170)		(4,170)
Equity compensation expense	306	$ 306
Payment to repurchase common stock (in shares)		(10,177)
Payment to repurchase common stock	(278)		(278)
Issuance of restricted stock (in shares)		50,289
Proceeds from sale of common stock (in shares)		8,539
Proceeds from sale of common stock	$ 236	$ 236
Ending balance (in shares) at Mar. 31, 2026	11,271,014	11,271,014
Balance at end of period at Mar. 31, 2026	$ 286,784	$ 74,368	$ 245,001	$ (32,585)